Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLEC2D - Acute alcohol consumption effect on whole blood (control group): time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CLEC2D - Chronic lymphocytic leukemia cells response to the neutralization of inhibitor of apoptosis proteins
CLEC2D - SRPIN803 small molecule inhibitor of SRPK1 effect on retinal pigment epithelial cell line
CLEC2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLEC2D - Interleukin 17A effect on monocyte-derived dendritic cells
CLEC2D - PI3K/mTOR Inhibitor NVP-BEZ235 and taxotere effects on prostate cancer xenograft tumors
CLEC2D - Anti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [HG-U133_Plus_2]
CLEC2D - Peroxisome proliferator-activated receptor β/δ agonist and hypoxia effects on umbilical vein endothelial cells
CLEC2D - In vitro myoblast differentiation: time course
CLEC2D - All-trans retinoic acid effect on HL60 myeloid cells overexpressing ecotropic virus integration site 1
CLEC2D - All-trans retinoic acid effect on U937 myeloid cells overexpressing ecotropic virus integration site 1
CLEC2D - A 3-D ex vivo model of oral wound healing: primary gingival fibroblasts
CLEC2D - Human and chimpanzee TS12KOS vector-generated induced pluripotent stem cells
CLEC2D - Ethanol effect on lymphoblastoid cell lines from alcoholics
CLEC2D - Hutchinson Gilford Progeria Syndrome cell line response to oncogenic challenge
CLEC2D - Psoriasis response to brodalumab: dose response and time course
CLEC2D - Glucose effect on steroid receptor coactivator 1 deficient-A549 lung cancer epithelial cell line
CLEC2D - H1 and H9 embryonic stem cell lines undergoing differentiation
CLEC2D - Imatinib mesylate effect on EOL-1 eosinophilic leukemia cell line
CLEC2D - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on